Statin treatment: can genetics sharpen the focus?

Affiliations

¹ Deutsches Herzzentrum München and Technische Universität München, DZHK Munich Heart Alliance, D-80636 Munich, Germany. Electronic address: schunkert@dhm.mhn.de.
² Department of Cardiovascular Sciences, University of Leicester, and NIHR Leicester Cardiovascular Biomedical Research Unit, BHF Cardiovascular Research Centre, Leicester, UK.

Comment

Heribert Schunkert et al. Lancet. 2015.

. 2015 Jun 6;385(9984):2227-9.

doi: 10.1016/S0140-6736(14)61931-0. Epub 2015 Mar 4.

¹ Deutsches Herzzentrum München and Technische Universität München, DZHK Munich Heart Alliance, D-80636 Munich, Germany. Electronic address: schunkert@dhm.mhn.de.
² Department of Cardiovascular Sciences, University of Leicester, and NIHR Leicester Cardiovascular Biomedical Research Unit, BHF Cardiovascular Research Centre, Leicester, UK.

No abstract available

Comment on

Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials.
Mega JL, Stitziel NO, Smith JG, Chasman DI, Caulfield M, Devlin JJ, Nordio F, Hyde C, Cannon CP, Sacks F, Poulter N, Sever P, Ridker PM, Braunwald E, Melander O, Kathiresan S, Sabatine MS. Mega JL, et al. Lancet. 2015 Jun 6;385(9984):2264-2271. doi: 10.1016/S0140-6736(14)61730-X. Epub 2015 Mar 4. Lancet. 2015. PMID: 25748612 Free PMC article.